Overview

Prediction and Prevention of Twin Premature Birth 2021

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
0
Participant gender:
Female
Summary
Research Objectives: 1. Establish a prediction and scoring system for twin premature birth. 2. To investigate the curative effect of 200mg,400mg and 600mg of vaginal progesterone in the prevention of twin premature birth. 3. To investigate the effect of stress cervical ligation in preventing premature delivery of twins. 4. The optimal dose of atosiban for the treatment of twin premature birth. 5. The influence of delivery mode on twin premature infants under 32 weeks.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Caixia Liu
Treatments:
Progesterone
Criteria
Inclusion Criteria:

twins with cervical length ≤ 25 mm by vaginal ultrasound at 14-32 weeks no contractions,
abdominal pain and vaginal bleeding No complicated twin complications occurred during
pregnancy

Exclusion Criteria:

Patients undergoing selective cervical ligation before 14 weeks of gestation history of
liver problems or cholestasis during pregnancy Abnormal liver enzymes Abnormal renal
function Local allergy to trace natural progesterone Recurrent vaginal bleeding Recurrent
vaginal infection Ultrasound diagnosis of fetal abnormality Intrauterine treatment for
fetal abnormalities